FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075716878> ?p ?o ?g. }

• W2075716878 endingPage "95" @default.
• W2075716878 startingPage "85" @default.
• W2075716878 abstract "Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a poorly understood pathologic entity from the standpoints of its nomenclature, frequency, pathogenesis, and best method of treatment. In particular, numerous recommendations have been made for treatment involving nonsurgical therapy. It is the purpose of this article to specifically examine the success of resection of the necrotic bone in the mandible and maxilla in these patients.We identified 103 sites of BRONJ in 82 patients. Of these sites of osteonecrosis, 32 were in the maxilla and 71 were in the mandible. Of the patients, 30 were taking an oral bisphosphonate medication whereas 52 were taking a parenteral bisphosphonate medication. Resection was performed in 95 sites of osteonecrosis in 74 patients, whereas 8 sites diagnosed in 8 patients were not resected. A total of 27 sites of BRONJ were resected in patients treated with oral bisphosphonates, and 68 sites of BRONJ were resected in patients treated with parenteral bisphosphonates.Of the 95 resected sites, 87 (91.6%) healed in an acceptable fashion with resolution of disease. Of 27 resected sites in patients taking an oral bisphosphonate medication, 26 (96.3%) healed satisfactorily, with refractory disease developing in 1 site. Of 68 resected sites in patients taking a parenteral bisphosphonate medication, 61 (89.7%) healed satisfactorily, with refractory disease developing in 7 sites. All 29 patients (100%) undergoing resection of the maxilla related to either an oral or parenteral bisphosphonate healed acceptably. The 8 patients who had the development of refractory disease did so with a range of 7 to 250 days postoperatively (mean, 73 days). Of the 8 sites of refractory disease, 6 developed after a marginal resection of the mandible for BRONJ. Three sites of new primary disease developed in 2 patients postoperatively. Both patients were taking a parenteral bisphosphonate medication. Histologic examination of the resected specimens identified malignant disease in 4 specimens in 3 patients.Resection of BRONJ permits acceptable healing in patients taking an oral bisphosphonate medication. In addition, resection of BRONJ of the maxilla in patients taking an oral or parenteral bisphosphonate medication follows a predictable course with regard to healing. Resection of BRONJ of the mandible in patients taking a parenteral bisphosphonate medication follows a variable postoperative course, although a high degree of success is realized. Surgeons should consider resection of necrotic bone of the maxilla and mandible that develops in patients taking bisphosphonate medications. In addition, refractory disease can be successfully managed with a more aggressive resection, specifically, a segmental resection of the mandible after a marginal resection of the mandible where refractory disease developed." @default.
• W2075716878 created "2016-06-24" @default.
• W2075716878 creator A5004771460 @default.
• W2075716878 creator A5053724773 @default.
• W2075716878 date "2009-05-01" @default.
• W2075716878 modified "2023-10-14" @default.
• W2075716878 title "The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the Jaws" @default.
• W2075716878 cites W1971844177 @default.
• W2075716878 cites W1972216430 @default.
• W2075716878 cites W1974788477 @default.
• W2075716878 cites W1976711506 @default.
• W2075716878 cites W1988968838 @default.
• W2075716878 cites W1989847784 @default.
• W2075716878 cites W1990119475 @default.
• W2075716878 cites W2002308161 @default.
• W2075716878 cites W201366182 @default.
• W2075716878 cites W2022400490 @default.
• W2075716878 cites W2047673455 @default.
• W2075716878 cites W2054201646 @default.
• W2075716878 cites W2060736857 @default.
• W2075716878 cites W2062366350 @default.
• W2075716878 cites W2072396430 @default.
• W2075716878 cites W2076157012 @default.
• W2075716878 cites W2076950276 @default.
• W2075716878 cites W2091069677 @default.
• W2075716878 cites W2097855124 @default.
• W2075716878 cites W2106960270 @default.
• W2075716878 cites W2137302084 @default.
• W2075716878 cites W2158285881 @default.
• W2075716878 cites W2160102488 @default.
• W2075716878 cites W2163515360 @default.
• W2075716878 cites W2163852287 @default.
• W2075716878 cites W2166925007 @default.
• W2075716878 cites W2167120343 @default.
• W2075716878 cites W2169512870 @default.
• W2075716878 cites W2341279955 @default.
• W2075716878 cites W282464114 @default.
• W2075716878 cites W4211173533 @default.
• W2075716878 cites W4321059790 @default.
• W2075716878 cites W4376595748 @default.
• W2075716878 doi "https://doi.org/10.1016/j.joms.2009.01.006" @default.
• W2075716878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19371819" @default.
• W2075716878 hasPublicationYear "2009" @default.
• W2075716878 type Work @default.
• W2075716878 sameAs 2075716878 @default.
• W2075716878 citedByCount "272" @default.
• W2075716878 countsByYear W20757168782012 @default.
• W2075716878 countsByYear W20757168782013 @default.
• W2075716878 countsByYear W20757168782014 @default.
• W2075716878 countsByYear W20757168782015 @default.
• W2075716878 countsByYear W20757168782016 @default.
• W2075716878 countsByYear W20757168782017 @default.
• W2075716878 countsByYear W20757168782018 @default.
• W2075716878 countsByYear W20757168782019 @default.
• W2075716878 countsByYear W20757168782020 @default.
• W2075716878 countsByYear W20757168782021 @default.
• W2075716878 countsByYear W20757168782022 @default.
• W2075716878 countsByYear W20757168782023 @default.
• W2075716878 crossrefType "journal-article" @default.
• W2075716878 hasAuthorship W2075716878A5004771460 @default.
• W2075716878 hasAuthorship W2075716878A5053724773 @default.
• W2075716878 hasConcept C121332964 @default.
• W2075716878 hasConcept C122246415 @default.
• W2075716878 hasConcept C126322002 @default.
• W2075716878 hasConcept C141071460 @default.
• W2075716878 hasConcept C142424586 @default.
• W2075716878 hasConcept C157369684 @default.
• W2075716878 hasConcept C199343813 @default.
• W2075716878 hasConcept C2776541429 @default.
• W2075716878 hasConcept C2777251235 @default.
• W2075716878 hasConcept C2777556957 @default.
• W2075716878 hasConcept C2779134260 @default.
• W2075716878 hasConcept C2779767645 @default.
• W2075716878 hasConcept C59822182 @default.
• W2075716878 hasConcept C71924100 @default.
• W2075716878 hasConcept C86803240 @default.
• W2075716878 hasConcept C87355193 @default.
• W2075716878 hasConceptScore W2075716878C121332964 @default.
• W2075716878 hasConceptScore W2075716878C122246415 @default.
• W2075716878 hasConceptScore W2075716878C126322002 @default.
• W2075716878 hasConceptScore W2075716878C141071460 @default.
• W2075716878 hasConceptScore W2075716878C142424586 @default.
• W2075716878 hasConceptScore W2075716878C157369684 @default.
• W2075716878 hasConceptScore W2075716878C199343813 @default.
• W2075716878 hasConceptScore W2075716878C2776541429 @default.
• W2075716878 hasConceptScore W2075716878C2777251235 @default.
• W2075716878 hasConceptScore W2075716878C2777556957 @default.
• W2075716878 hasConceptScore W2075716878C2779134260 @default.
• W2075716878 hasConceptScore W2075716878C2779767645 @default.
• W2075716878 hasConceptScore W2075716878C59822182 @default.
• W2075716878 hasConceptScore W2075716878C71924100 @default.
• W2075716878 hasConceptScore W2075716878C86803240 @default.
• W2075716878 hasConceptScore W2075716878C87355193 @default.
• W2075716878 hasIssue "5" @default.
• W2075716878 hasLocation W20757168781 @default.
• W2075716878 hasLocation W20757168782 @default.
• W2075716878 hasOpenAccess W2075716878 @default.
• W2075716878 hasPrimaryLocation W20757168781 @default.

• next